ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

Cite this: J. Med. Chem. 1993, 36, 20, 3032–3034
Publication Date (Print):October 1, 1993
https://doi.org/10.1021/jm00072a026
    ACS Legacy Archive

    Article Views

    589

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options
    Supporting Info (1)»

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information


    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 258 publications.

    1. Ganesh A. Thakur, Shama Bajaj, Carol Paronis, Yan Peng, Anna L. Bowman, Lawrence S. Barak, Marc G. Caron, Demon Parrish, Jeffrey R. Deschamps, and Alexandros Makriyannis . Novel Adamantyl Cannabinoids as CB1 Receptor Probes. Journal of Medicinal Chemistry 2013, 56 (10) , 3904-3921. https://doi.org/10.1021/jm4000775
    2. Sharon M. Sagnella, Charlotte E. Conn, Irena Krodkiewska, Minoo Moghaddam, John M. Seddon and Calum J. Drummond . Ordered Nanostructured Amphiphile Self-Assembly Materials from Endogenous Nonionic Unsaturated Monoethanolamide Lipids in Water. Langmuir 2010, 26 (5) , 3084-3094. https://doi.org/10.1021/la903005q
    3. John Williams,, JodiAnne Wood,, Lakshmipathi Pandarinathan,, David A. Karanian,, Ben A. Bahr,, Paul Vouros, and, Alexandros Makriyannis. Quantitative Method for the Profiling of the Endocannabinoid Metabolome by LC-Atmospheric Pressure Chemical Ionization-MS. Analytical Chemistry 2007, 79 (15) , 5582-5593. https://doi.org/10.1021/ac0624086
    4. Didier M. Lambert and, Christopher J. Fowler. The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications. Journal of Medicinal Chemistry 2005, 48 (16) , 5059-5087. https://doi.org/10.1021/jm058183t
    5. Judy Barnett-Norris,, Dow P. Hurst,, Diane L. Lynch,, Frank Guarnieri,, Alex Makriyannis, and, Patricia H. Reggio. Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor. Journal of Medicinal Chemistry 2002, 45 (17) , 3649-3659. https://doi.org/10.1021/jm0200761
    6. Edward W. Ng,, Mie Mie Aung,, Mary E. Abood,, Billy R. Martin, and, Raj K. Razdan. Unique Analogues of Anandamide:  Arachidonyl Ethers and Carbamates and Norarachidonyl Carbamates and Ureas. Journal of Medicinal Chemistry 1999, 42 (11) , 1975-1981. https://doi.org/10.1021/jm980711w
    7. Wensheng Lang,, Ce Qin,, Sonyuan Lin,, Atmaram D. Khanolkar,, Andreas Goutopoulos,, Pusheng Fan,, Khaled Abouzid,, Zhaoxing Meng,, Diane Biegel, and, Alexandros Makriyannis. Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase. Journal of Medicinal Chemistry 1999, 42 (5) , 896-902. https://doi.org/10.1021/jm980461j
    8. Sonyuan Lin,, Atmaram D. Khanolkar,, Pusheng Fan,, Andreas Goutopoulos,, Ce Qin,, Demetris Papahadjis, and, Alexandros Makriyannis. Novel Analogues of Arachidonylethanolamide (Anandamide):  Affinities for the CB1 and CB2 Cannabinoid Receptors and Metabolic Stability. Journal of Medicinal Chemistry 1998, 41 (27) , 5353-5361. https://doi.org/10.1021/jm970257g
    9. Weida Tong,, Elizabeth R. Collantes, and, William J. Welsh, , Barbara A. Berglund and, Allyn C. Howlett. Derivation of a Pharmacophore Model for Anandamide Using Constrained Conformational Searching and Comparative Molecular Field Analysis. Journal of Medicinal Chemistry 1998, 41 (22) , 4207-4215. https://doi.org/10.1021/jm970239z
    10. William J. Ryan,, W. Kenneth Banner,, Jenny L. Wiley,, Billy R. Martin, and, Raj K. Razdan. Potent Anandamide Analogs:  The Effect of Changing the Length and Branching of the End Pentyl Chain. Journal of Medicinal Chemistry 1997, 40 (22) , 3617-3625. https://doi.org/10.1021/jm970212f
    11. Tzviel Sheskin,, Lumir Hanuš,, Joram Slager,, Zvi Vogel, and, Raphael Mechoulam. Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor. Journal of Medicinal Chemistry 1997, 40 (5) , 659-667. https://doi.org/10.1021/jm960752x
    12. Brian F. Thomas,, Irma B. Adams,, S. Wayne Mascarella,, Billy R. Martin, and, Raj K. Razdan. Structure−Activity Analysis of Anandamide Analogs:  Relationship to a Cannabinoid Pharmacophore. Journal of Medicinal Chemistry 1996, 39 (2) , 471-479. https://doi.org/10.1021/jm9505167
    13. A Pařízek, J Suchopár, Z Laštůvka, M Alblová, M Hill, M Dušková. The Endocannabinoid System and Its Relationship to Human Reproduction. Physiological Research 2023, , S365-S380. https://doi.org/10.33549/physiolres.935229
    14. Natalya M. Kogan, Dilorom Begmatova, Liudmila Vinnikova, Sergey Malitsky, Maxim Itkin, Eyal Sharon, Artem Klinov, Jonathan Gorelick, Igor Koman, Zvi Vogel, Raphael Mechoulam, Albert Pinhasov. Endocannabinoid basis of personality—Insights from animal model of social behavior. Frontiers in Pharmacology 2023, 14 https://doi.org/10.3389/fphar.2023.1234332
    15. Lan Jiang, Xiaochun Gai, Ya Ni, Ting Qiang, Yingying Zhang, Xiao Kang, Ke Xiong, Jinyu Wang. Folic acid protects against tuberculosis-drug-induced liver injury in rats and its potential mechanism by metabolomics. The Journal of Nutritional Biochemistry 2023, 112 , 109214. https://doi.org/10.1016/j.jnutbio.2022.109214
    16. Raphael Mechoulam. A Delightful Trip Along the Pathway of Cannabinoid and Endocannabinoid Chemistry and Pharmacology. Annual Review of Pharmacology and Toxicology 2023, 63 (1) , 1-13. https://doi.org/10.1146/annurev-pharmtox-051921-083709
    17. Isabel Baenas, Romina Miranda-Olivos, Roser Granero, Neus Solé-Morata, Isabel Sánchez, Antoni Pastor, Amparo del Pino-Gutiérrez, Ester Codina, Francisco J. Tinahones, José A. Fernández-Formoso, Núria Vilarrasa, Fernando Guerrero-Pérez, Rafael Lopez-Urdiales, Núria Virgili, Carles Soriano-Mas, Susana Jiménez-Murcia, Rafael de la Torre, Fernando Fernández-Aranda. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity. European Psychiatry 2023, 66 (1) https://doi.org/10.1192/j.eurpsy.2023.2411
    18. Jyoti Sihag, Vincenzo Di Marzo. (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders. Lipids in Health and Disease 2022, 21 (1) https://doi.org/10.1186/s12944-021-01609-3
    19. Judah Glogauer, Jonathan Blay. Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis. Cancer Reports 2022, 5 (2) https://doi.org/10.1002/cnr2.1475
    20. Michael H. Myoga, Wade G. Regehr. Cannabinoids and Synaptic Transmission in the Cerebellum. 2022, 1005-1023. https://doi.org/10.1007/978-3-030-23810-0_39
    21. Sukanya Arul Prakash, Ravi Kanth Kamlekar. Function and therapeutic potential of N-acyl amino acids. Chemistry and Physics of Lipids 2021, 239 , 105114. https://doi.org/10.1016/j.chemphyslip.2021.105114
    22. Cristina Sempio, Jelena Klawitter, Matthew Jackson, Francesca Freni, Ryan Shillingburg, Kent Hutchison, L. Cinnamon Bidwell, Uwe Christians, Jost Klawitter. Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography–mass spectrometry. Analytical and Bioanalytical Chemistry 2021, 413 (12) , 3381-3392. https://doi.org/10.1007/s00216-021-03280-0
    23. Xin Chien Lee, Evelyn Werner, Marco Falasca. Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer. Cancers 2021, 13 (6) , 1211. https://doi.org/10.3390/cancers13061211
    24. Tristyn L. Clarke, Rachael L. Johnson, Jonathan J. Simone, Robert L. Carlone. The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration. International Journal of Molecular Sciences 2021, 22 (4) , 2103. https://doi.org/10.3390/ijms22042103
    25. Engin YÜCEL, Zühal AKTUNA, İsmail Semih KESKİL. Effects of endocannabinoids in pentylenetetrazole induced seizures in mice. Acta Medica Alanya 2020, 4 (3) , 209-215. https://doi.org/10.30565/medalanya.690410
    26. , , Aruna Kilaru, Kent D. Chapman. The endocannabinoid system. Essays in Biochemistry 2020, 64 (3) , 485-499. https://doi.org/10.1042/EBC20190086
    27. Lumír Ondřej Hanuš, Yotam Hod. Terpenes/Terpenoids in Cannabis: Are They Important?. Medical Cannabis and Cannabinoids 2020, 3 (1) , 25-60. https://doi.org/10.1159/000509733
    28. Carla Ferreira, Catarina Almeida, Sandra Tenreiro, Alexandre Quintas. Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease. Life 2020, 10 (6) , 86. https://doi.org/10.3390/life10060086
    29. Pal Pacher, Natalya M. Kogan, Raphael Mechoulam. Beyond THC and Endocannabinoids. Annual Review of Pharmacology and Toxicology 2020, 60 (1) , 637-659. https://doi.org/10.1146/annurev-pharmtox-010818-021441
    30. Mariah M. Wu, Xinwen Zhang, Melissa J. Asher, Stanley A. Thayer. Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder. Brain Research 2019, 1724 , 146467. https://doi.org/10.1016/j.brainres.2019.146467
    31. Jyoti Sihag, Peter J.H. Jones. Dietary fatty acid profile influences circulating and tissue fatty acid ethanolamide concentrations in a tissue-specific manner in male Syrian hamsters. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019, 1864 (11) , 1563-1579. https://doi.org/10.1016/j.bbalip.2019.07.002
    32. Luis Apaza T., Victor Tena Pérez, Andreea Madalina Serban, Matías J. Alonso Navarro, Angel Rumbero. Alkamides from Tropaeolum tuberosum inhibit inflammatory response induced by TNF–α and NF–κB. Journal of Ethnopharmacology 2019, 235 , 199-205. https://doi.org/10.1016/j.jep.2019.02.015
    33. Burkhard Hinz, Robert Ramer. Anti‐tumour actions of cannabinoids. British Journal of Pharmacology 2019, 176 (10) , 1384-1394. https://doi.org/10.1111/bph.14426
    34. Lauren N. Carnevale, Aditi Das. Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. 2019, 219-232. https://doi.org/10.1007/978-3-030-21735-8_17
    35. Nahed Alharthi, Peter Christensen, Wafa Hourani, Catherine Ortori, David A. Barrett, Andrew J. Bennett, Victoria Chapman, Stephen P.H. Alexander. n−3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018, 1863 (11) , 1433-1440. https://doi.org/10.1016/j.bbalip.2018.08.003
    36. Janos Paloczi, Zoltan V. Varga, George Hasko, Pal Pacher. Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation. Antioxidants & Redox Signaling 2018, 29 (1) , 75-108. https://doi.org/10.1089/ars.2017.7144
    37. Rico Schwarz, Robert Ramer, Burkhard Hinz. Targeting the endocannabinoid system as a potential anticancer approach. Drug Metabolism Reviews 2018, 50 (1) , 26-53. https://doi.org/10.1080/03602532.2018.1428344
    38. Jyoti Sihag, Peter J. H. Jones. Dietary fatty acid composition impacts plasma fatty acid ethanolamide levels and body composition in golden Syrian hamsters. Food & Function 2018, 9 (6) , 3351-3362. https://doi.org/10.1039/C8FO00621K
    39. Vadim Shevyrin, Vladimir Melkozerov, Gregory W. Endres, Yuri Shafran, Yuri Morzherin. On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances. Cannabis and Cannabinoid Research 2016, 1 (1) , 186-194. https://doi.org/10.1089/can.2016.0004
    40. Vino Daniel. Central Analgesic Activity. 2016, 1785-1874. https://doi.org/10.1007/978-3-319-05392-9_40
    41. Lenita Lindgren, Sandra Gouveia-Figueira, Malin L. Nording, Christopher J. Fowler. Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study. BMC Research Notes 2015, 8 (1) https://doi.org/10.1186/s13104-015-1450-z
    42. Ming Qi, Maria Morena, Haley A. Vecchiarelli, Matthew N. Hill, David C. Schriemer. A robust capillary liquid chromatography/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids. Rapid Communications in Mass Spectrometry 2015, 29 (20) , 1889-1897. https://doi.org/10.1002/rcm.7277
    43. Luis A. Natividad, Paola Maccioni, Loren H. Parsons, Giancarlo Colombo. Cannabinoid-Alcohol Interactions. 2015, 363-391. https://doi.org/10.1007/978-1-4939-2294-9_14
    44. Roger G. Pertwee. Endocannabinoids and Their Pharmacological Actions. 2015, 1-37. https://doi.org/10.1007/978-3-319-20825-1_1
    45. Bandana Chakravarti, Janani Ravi, Ramesh K. Ganju. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget 2014, 5 (15) , 5852-5872. https://doi.org/10.18632/oncotarget.2233
    46. Filomena Fezza, Mauro Maccarrone. Endocannabinoid biochemistry: What do we know after 50 years?. 2014, 53-94. https://doi.org/10.1002/9781118451281.ch3
    47. Karen Kleberg, Helle A. Hassing, Harald S. Hansen. Classical endocannabinoid‐like compounds and their regulation by nutrients. BioFactors 2014, 40 (4) , 363-372. https://doi.org/10.1002/biof.1158
    48. Vino Daniel. Central Analgesic Activity. 2014, 1-104. https://doi.org/10.1007/978-3-642-27728-3_40-1
    49. J.D. Figueroa, K. Cordero, M. Serrano-Illan, A. Almeyda, K. Baldeosingh, F.G. Almaguel, M. De Leon. Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury. Neuroscience 2013, 255 , 1-18. https://doi.org/10.1016/j.neuroscience.2013.09.012
    50. Hsiu-Wen Chan, Natalie C McKirdy, Hassendrini N Peiris, Gregory E Rice, Murray D Mitchell. The role of endocannabinoids in pregnancy. REPRODUCTION 2013, 146 (3) , R101-R109. https://doi.org/10.1530/REP-12-0508
    51. David Balgoma, Antonio Checa, Daniel García Sar, Stuart Snowden, Craig E. Wheelock. Quantitative metabolic profiling of lipid mediators. Molecular Nutrition & Food Research 2013, 57 (8) , 1359-1377. https://doi.org/10.1002/mnfr.201200840
    52. Jahan Marcu, Linda Console-Bram, Mary E. Abood. Current Cannabinoid Receptor Nomenclature and Pharmacological Principles. 2013, 25-54. https://doi.org/10.1007/978-1-4614-7940-6_3
    53. Michael H. Myoga, Wade G. Regehr. Cannabinoids and Synaptic Transmission in the Cerebellum. 2013, 927-946. https://doi.org/10.1007/978-94-007-1333-8_39
    54. Tsukasa Ishida, Shin Nishiumi, Toshihito Tanahashi, Akifumi Yamasaki, Asahi Yamazaki, Takahiro Akashi, Ikuya Miki, Yasuyuki Kondo, Jun Inoue, Shoji Kawauchi, Takeshi Azuma, Masaru Yoshida, Shigeto Mizuno. Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice. European Journal of Pharmacology 2013, 699 (1-3) , 6-13. https://doi.org/10.1016/j.ejphar.2012.11.030
    55. Hee-Yong Kim, Arthur A. Spector. Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2013, 88 (1) , 121-125. https://doi.org/10.1016/j.plefa.2012.08.002
    56. Roberta Ottria, Silvana Casati, Pierangela Ciuffreda. 1 H, 13 C and 15 N NMR assignments for N ‐ and O ‐acylethanolamines, important family of naturally occurring bioactive lipid mediators. Magnetic Resonance in Chemistry 2012, 50 (12) , 823-828. https://doi.org/10.1002/mrc.3891
    57. Linda Console-Bram, Jahan Marcu, Mary E. Abood. Cannabinoid receptors: nomenclature and pharmacological principles. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 38 (1) , 4-15. https://doi.org/10.1016/j.pnpbp.2012.02.009
    58. CJ Fowler. Monoacylglycerol lipase – a target for drug development?. British Journal of Pharmacology 2012, 166 (5) , 1568-1585. https://doi.org/10.1111/j.1476-5381.2012.01950.x
    59. Matthew J. Pava, John J. Woodward. A review of the interactions between alcohol and the endocannabinoid system: Implications for alcohol dependence and future directions for research. Alcohol 2012, 46 (3) , 185-204. https://doi.org/10.1016/j.alcohol.2012.01.002
    60. Saoirse E O’Sullivan, Patrick J Kendall, David A Kendall. Endocannabinoids and the cardiovascular response to stress. Journal of Psychopharmacology 2012, 26 (1) , 71-82. https://doi.org/10.1177/0269881111408457
    61. George Kokotos. Endocannabinoids. 2012, 245-264. https://doi.org/10.1533/9780857097934.245
    62. Nimish Sidhpura, Loren H. Parsons. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 2011, 61 (7) , 1070-1087. https://doi.org/10.1016/j.neuropharm.2011.05.034
    63. Antonia Serrano, Loren H. Parsons. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Pharmacology & Therapeutics 2011, 132 (3) , 215-241. https://doi.org/10.1016/j.pharmthera.2011.06.005
    64. Torbjörn U. C. Järbe. Perceptual Drug Discriminative Aspects of the Endocannabinoid Signaling System in Animals And Man. 2011, 241-285. https://doi.org/10.1002/9781118023150.ch8
    65. J. Donovan, D. Grundy. The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum. Neurogastroenterology & Motility 2011, 23 (6) , 567-e209. https://doi.org/10.1111/j.1365-2982.2011.01693.x
    66. Michael R. Ruggieri. Cannabinoids: Potential Targets for Bladder Dysfunction. 2011, 425-451. https://doi.org/10.1007/978-3-642-16499-6_20
    67. Natsuo Ueda, Kazuhito Tsuboi, Toru Uyama. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2010, 1801 (12) , 1274-1285. https://doi.org/10.1016/j.bbalip.2010.08.010
    68. Eduardo Tibiriça. The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. Diabetology & Metabolic Syndrome 2010, 2 (1) https://doi.org/10.1186/1758-5996-2-5
    69. Cyrine Ezzili, Katerina Otrubova, Dale L. Boger. Fatty acid amide signaling molecules. Bioorganic & Medicinal Chemistry Letters 2010, 20 (20) , 5959-5968. https://doi.org/10.1016/j.bmcl.2010.08.048
    70. Natsuo Ueda, Kazuhito Tsuboi, Toru Uyama. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Progress in Lipid Research 2010, 49 (4) , 299-315. https://doi.org/10.1016/j.plipres.2010.02.003
    71. Harald S. Hansen. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Experimental Neurology 2010, 224 (1) , 48-55. https://doi.org/10.1016/j.expneurol.2010.03.022
    72. Dimitris Anagnostopoulos, Carmelina Rakiec, Jodi Wood, Lakshmipathi Pandarinathan, Nikolai Zvonok, Alexandros Makriyannis, Athanasia Siafaka-Kapadai. Identification of Endocannabinoids and Related N-Acylethanolamines in Tetrahymena. A New Class of Compounds for Tetrahymena. Protist 2010, 161 (3) , 452-465. https://doi.org/10.1016/j.protis.2009.12.004
    73. Michelle R. Hoot, Laura J. Sim-Selley, Justin L. Poklis, Rehab A. Abdullah, Krista L. Scoggins, Dana E. Selley, William L. Dewey. Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice. Brain Research 2010, 1339 , 18-25. https://doi.org/10.1016/j.brainres.2010.03.105
    74. Matthew W Buczynski, Loren H Parsons. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. British Journal of Pharmacology 2010, 160 (3) , 423-442. https://doi.org/10.1111/j.1476-5381.2010.00787.x
    75. Jeong Jun Han, Jae Kwang Song, Joon Shick Rhee, Suk Hoo Yoon. Biotechnological Uses of Phospholipids. 2010, 277-298. https://doi.org/10.1002/9780470608524.ch19
    76. Dana Turcotte, Josée-Anne Le Dorze, Farid Esfahani, Emma Frost, Andrew Gomori, Mike Namaka. Examining the roles of cannabinoids in pain and other therapeutic indications: a review. Expert Opinion on Pharmacotherapy 2010, 11 (1) , 17-31. https://doi.org/10.1517/14656560903413534
    77. Saveria Aquila, Carmela Guido, Chiara Laezza, Antonietta Santoro, Vincenzo Pezzi, Salvatore Panza, Sebastiano Andò, Maurizio Bifulco. A new role of anandamide in human sperm: Focus on metabolism. Journal of Cellular Physiology 2009, 221 (1) , 147-153. https://doi.org/10.1002/jcp.21837
    78. Giuseppe Astarita, Daniele Piomelli. Lipidomic analysis of endocannabinoid metabolism in biological samples. Journal of Chromatography B 2009, 877 (26) , 2755-2767. https://doi.org/10.1016/j.jchromb.2009.01.008
    79. Philip J. Kingsley, Lawrence J. Marnett. Analysis of endocannabinoids, their congeners and COX-2 metabolites. Journal of Chromatography B 2009, 877 (26) , 2746-2754. https://doi.org/10.1016/j.jchromb.2009.05.024
    80. María Martínez de Ubago, Inmaculada García-Oya, Antonio Pérez-Pérez, Alberto Canfrán-Duque, Rocio Quintana-Portillo, Fernando Rodríguez de Fonseca, Carmen González-Yanes, Víctor Sánchez-Margalet. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009, 1791 (8) , 740-745. https://doi.org/10.1016/j.bbalip.2009.03.014
    81. Michiel G.J. Balvers, Kitty C.M. Verhoeckx, Renger F. Witkamp. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 2009, 877 (14-15) , 1583-1590. https://doi.org/10.1016/j.jchromb.2009.04.010
    82. Lumír Ondřej Hanuš. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medicinal Research Reviews 2009, 29 (2) , 213-271. https://doi.org/10.1002/med.20135
    83. Tiziana Bisogno, Fabiana Piscitelli, Vincenzo Di Marzo. Lipidomic methodologies applicable to the study of endocannabinoids and related compounds: Endocannabinoidomics. European Journal of Lipid Science and Technology 2009, 111 (1) , 53-63. https://doi.org/10.1002/ejlt.200800233
    84. S. Petrosino, V. Di Marzo. Anandamide and Other Acylethanolamides. 2009, 75-98. https://doi.org/10.1007/978-0-387-30378-9_5
    85. V. Kiran Vemuri, Alexandros Makriyannis. Endocannabinoids and Their Synthetic Analogs. 2009, 21-48. https://doi.org/10.1007/978-1-59745-503-9_2
    86. Mary E. Abood. Molecular Biology of Cannabinoid Receptors: Mutational Analyses of the CB Receptors. 2009, 203-234. https://doi.org/10.1007/978-1-59745-503-9_8
    87. Stephen P. H. Alexander, David A. Kendall. The Life Cycle of the Endocannabinoids: Formation and Inactivation. 2009, 3-35. https://doi.org/10.1007/978-3-540-88955-7_1
    88. Giuseppe Astarita, Jennifer Geaga, Faizy Ahmed, Daniele Piomelli. Chapter 4 Targeted Lipidomics as a Tool to Investigate Endocannabinoid Function. 2009, 35-55. https://doi.org/10.1016/S0074-7742(09)85004-6
    89. Masanobu Kano, Takako Ohno-Shosaku, Yuki Hashimotodani, Motokazu Uchigashima, Masahiko Watanabe. Endocannabinoid-Mediated Control of Synaptic Transmission. Physiological Reviews 2009, 89 (1) , 309-380. https://doi.org/10.1152/physrev.00019.2008
    90. Jing Chen, Kalpana S. Paudel, Andrei V. Derbenev, Bret N. Smith, Audra L. Stinchcomb. Simultaneous Quantification of Anandamide and Other Endocannabinoids in Dorsal Vagal Complex of Rat Brainstem by LC–MS. Chromatographia 2009, 69 (1-2) , 1-7. https://doi.org/10.1365/s10337-008-0841-x
    91. Jing Chen Xiao, James P. Jewell, Linus S. Lin, William K. Hagmann, Tung M. Fong, Chun-Pyn Shen. Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells. Brain Research 2008, 1238 , 36-43. https://doi.org/10.1016/j.brainres.2008.08.027
    92. Artur Dembiński, Zygmunt Warzecha, Piotr Ceranowicz, Anna M. Warzecha, Wiesław W. Pawlik, Marcin Dembiński, Kazimierz Rembiasz, Paweł Sendur, Beata Kuśnierz-Cabala, Romana Tomaszewska, Eve Chowaniec, Peter C. Konturek. Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. European Journal of Pharmacology 2008, 591 (1-3) , 284-292. https://doi.org/10.1016/j.ejphar.2008.06.059
    93. Eric Horne, Nephi Stella. The ins and outs of endocannabinoid signaling in healthy and diseased brain. Future Lipidology 2008, 3 (4) , 435-452. https://doi.org/10.2217/17460875.3.4.435
    94. Giulio G. Muccioli, Nephi Stella. An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brain. Analytical Biochemistry 2008, 373 (2) , 220-228. https://doi.org/10.1016/j.ab.2007.09.030
    95. B. S. Basavarajappa, R. Yalamanchili, T. B. Cooper, B. L. Hungund. The Endocannabinoid System. 2008, 343-384. https://doi.org/10.1007/978-0-387-30382-6_14
    96. Heather B. Bradshaw. Other Cannabimimetic Lipid Signaling Molecules. 2008, 47-58. https://doi.org/10.1007/978-0-387-74349-3_4
    97. A M Miller, N Stella. CB 2 receptor‐mediated migration of immune cells: it can go either way. British Journal of Pharmacology 2008, 153 (2) , 299-308. https://doi.org/10.1038/sj.bjp.0707523
    98. Georg Juckel, Patrik Roser, Thomas Nadulski, Andreas M. Stadelmann, Jürgen Gallinat. Acute effects of Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophrenia Research 2007, 97 (1-3) , 109-117. https://doi.org/10.1016/j.schres.2007.08.015
    99. C J Fowler. The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action. British Journal of Pharmacology 2007, 152 (5) , 594-601. https://doi.org/10.1038/sj.bjp.0707379
    100. Susanna M. Saario, Jarmo T. Laitinen. Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors. Basic & Clinical Pharmacology & Toxicology 2007, 101 (5) , 287-293. https://doi.org/10.1111/j.1742-7843.2007.00130.x
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect